Evidence map›Paper›PMID 34130957›Full record

ArticleBMJ open2021

Areca nut consumption with and without tobacco among the adult population: a nationally representative study from India.

Prashant Kumar Singh, Amit Yadav, Lucky Singh, Sumit Mazumdar, Dhirendra N Sinha, Kurt Straif, Shalini Singh

Abstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Sociodemographic Factors, Attitudes, and Tobacco use among Adolescent Areca-Nut Users in Mumbai, India.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Prashant Kumar SinghDivision of Preventive Oncology & Population Health, ICMR - National Institute of Cancer Prevention and Research, Noida, India prashants.geo@gmail.com.ORCID 0000-0003-1742-5534
Amit YadavThe International Union Against Tuberculosis and Lung Disease (The Union) South East Asia Office, New Delhi, India.
Lucky SinghICMR - National Institute of Medical Statistics, New Delhi, India.
Sumit MazumdarCentre for Health Economics, University of York, Heslington, York, UK.ORCID 0000-0002-9278-4396
Dhirendra N SinhaSchool of Preventive Oncology, Patna, India.
Kurt StraifBoston College USA, Boston, Massachusetts, USA.
Shalini SinghWHO FCTC Global Knowledge Hub on Smokeless Tobacco, ICMR - National Institute of Cancer Prevention and Research, Noida, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAreca nut is one of the most widely consumed substances globally, after nicotine, ethanol and caffeine and classified as carcinogenic to humans. This study examines the disparity and determinants of areca nut consumption with and without tobacco in India.

designNationally representative cross-sectional study.

participantsWe used the nationally representative Global Adult Tobacco Survey 2016-2017. The analytical sample size was 74 037 individual's aged 15 years and above with a response rate of 92.9%. MEASURES: Current consumption of areca nut without tobacco and with tobacco.

methodWe examined determinants of areca nut consumption (without tobacco and with tobacco) using multinomial logistic regression, accounting for the survey design.

resultsAbout 23.9% (95% CI 23.1 to 24.8) of the adult population consume areca nut, that is, approximately 223.79 million people in India; majority of users (14.2%-95% CI 13.5 to 14.9) consumed areca nut with tobacco. When compared with women, men were more likely to consume areca nut (with tobacco relative risk (RR)=2.02; 95% CI 1.85 to 2.21 and without tobacco RR=1.13; 95% CI 1.07 to 1.20). Age, marital status, education, occupation, caste, religion and region were significantly associated with areca nut consumption. However, the direction and magnitude of association differ with respect to the areca nut consumption with and without tobacco.

conclusionThe ongoing tobacco control efforts would not address the majority of areca nut users until greater attention to areca nut consumption with and without tobacco is reflected in health policies in India.

Indexed as

ArecaTobacco UseAdultCross-Sectional StudiesFemaleHumansIndiaMaleNutsTobacco Productscancer painhealth policypublic health

Identifiers

PMID34130957
PMCPMC8208015

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.